Home » Newsletters » BioWorld

BioWorld

May 11, 1998

View Archived Issues

BIO, PhRMA Urge Patent Reform By Congressional Session's End

Appointments And Advancements

CombiChem IPO Raises $18M For Finding Drug Candidates

Transcend Sifts Phase III Data For Procysteine Failure Clues

Other News To Note

Immunex Files Enbrel BLA, Expects Priority FDA Review

Lasting Emotional Withdrawal Symptoms Outweigh 'Physical,' Addicted Rat Brains R

Cortech, BioStar Merger Kaput; Both Exploring Other Options